• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

验证英国多发性硬化症注册中心的门户人群。

Validating the portal population of the United Kingdom Multiple Sclerosis Register.

机构信息

Swansea University Medical School, Swansea, United Kingdom.

Swansea University Medical School, Swansea, United Kingdom.

出版信息

Mult Scler Relat Disord. 2018 Aug;24:3-10. doi: 10.1016/j.msard.2018.05.015. Epub 2018 May 25.

DOI:10.1016/j.msard.2018.05.015
PMID:29860199
Abstract

The UK Multiple Sclerosis Register (UKMSR) is a large cohort study designed to capture 'real world' information about living with multiple sclerosis (MS) in the UK from diverse sources. The primary source of data is directly from people with Multiple Sclerosis (pwMS) captured by longitudinal questionnaires via an internet portal. This population's diagnosis of MS is self-reported and therefore unverified. The second data source is clinical data which is captured from MS Specialist Treatment centres across the UK. This includes a clinically confirmed diagnosis of MS (by Macdonald criteria) for consented patients. A proportion of the internet population have also been consented at their hospital making comparisons possible. This dataset is called the 'linked dataset'. The purpose of this paper is to examine the characteristics of the three datasets: the self-reported portal data, clinical data and linked data, in order to assess the validity of the self-reported portal data. The internet (n = 11,021) and clinical (n = 3,003) populations were studied for key shared characteristics. We found them to be closely matched for mean age at diagnosis (clinical = 37.39, portal = 39.28) and gender ratio (female %, portal = 73.1, clinical = 75.2). The Two Sample Kolmogorov-Smirnov test was for the continuous variables to examine is they were drawn from the same distribution. The null hypothesis was rejected only for age at diagnosis (D = 0.078, p < 0.01). The populations therefore, were drawn from different distributions, as there are more patients with relapsing disease in the clinical cohort. In all other analyses performed, the populations were shown to be drawn from the same distribution. Our analysis has shown that the UKMSR portal population is highly analogous to the entirely clinical (validated) population. This supports the validity of the self-reported diagnosis and therefore that the portal population can be utilised as a viable and valid cohort of people with Multiple Sclerosis for study.

摘要

英国多发性硬化症登记处(UKMSR)是一项大型队列研究,旨在从多个来源收集英国多发性硬化症患者的“真实世界”信息。主要数据来源是通过互联网门户直接从多发性硬化症患者(pwMS)那里获取的纵向问卷调查。该人群的多发性硬化症诊断是自我报告的,因此未经证实。第二个数据源是来自英国各地多发性硬化症专科治疗中心的临床数据。这包括经麦克唐纳标准确认的多发性硬化症临床诊断(在获得同意的患者中)。一部分互联网人群也在其医院获得了同意,这使得比较成为可能。该数据集称为“链接数据集”。本文的目的是检查三个数据集(自我报告的门户数据、临床数据和链接数据)的特征,以评估自我报告的门户数据的有效性。研究了互联网(n=11021)和临床(n=3003)人群的关键共享特征。我们发现,它们在诊断时的平均年龄(临床=37.39,门户=39.28)和性别比例(女性%,门户=73.1,临床=75.2)方面非常匹配。双样本 Kolmogorov-Smirnov 检验用于检验连续变量是否来自同一分布。只有在诊断时的年龄这一变量上,零假设被拒绝(D=0.078,p<0.01)。这表明这两个群体来自不同的分布,因为临床队列中存在更多的复发型疾病患者。在进行的所有其他分析中,都表明这两个群体来自同一分布。我们的分析表明,UKMSR 门户人群与完全临床(验证)人群高度相似。这支持自我报告诊断的有效性,因此门户人群可以作为多发性硬化症患者的可行和有效队列进行研究。

相似文献

1
Validating the portal population of the United Kingdom Multiple Sclerosis Register.验证英国多发性硬化症注册中心的门户人群。
Mult Scler Relat Disord. 2018 Aug;24:3-10. doi: 10.1016/j.msard.2018.05.015. Epub 2018 May 25.
2
The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS.通过网络门户从多发性硬化症患者处收集信息用于英国多发性硬化症登记处的可行性:多发性硬化症患者队列的特征。
BMC Med Inform Decis Mak. 2012 Jul 18;12:73. doi: 10.1186/1472-6947-12-73.
3
Desirability and expectations of the UK MS Register: views of people with MS.英国多发性硬化症登记册的可取性和期望:多发性硬化症患者的观点。
Int J Med Inform. 2013 Nov;82(11):1104-10. doi: 10.1016/j.ijmedinf.2013.07.005. Epub 2013 Sep 7.
4
The characteristics of a national register of people with multiple sclerosis (MS): a comparison between the ARMS (Action for Research into Multiple Sclerosis) register and 10 British MS populations.多发性硬化症(MS)患者国家登记册的特征:ARMS(多发性硬化症研究行动)登记册与10个英国MS人群的比较。
J Epidemiol Community Health. 1989 Jun;43(2):179-86. doi: 10.1136/jech.43.2.179.
5
Recovery From COVID-19 in Multiple Sclerosis: A Prospective and Longitudinal Cohort Study of the United Kingdom Multiple Sclerosis Register.COVID-19 后多发性硬化症的恢复:英国多发性硬化症登记处的前瞻性和纵向队列研究。
Neurol Neuroimmunol Neuroinflamm. 2021 Nov 30;9(1). doi: 10.1212/NXI.0000000000001118. Print 2022 Jan.
6
A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register.一项针对多发性硬化症患者焦虑和抑郁的大规模研究:通过英国多发性硬化症注册中心的网络门户进行的调查。
PLoS One. 2012;7(7):e41910. doi: 10.1371/journal.pone.0041910. Epub 2012 Jul 30.
7
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
8
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK.ADAMS 项目:基于英国的多发性硬化症患者的多种族背景下的遗传关联研究。
BMJ Open. 2023 May 17;13(5):e071656. doi: 10.1136/bmjopen-2023-071656.
9
Validation of multiple sclerosis diagnoses in the Swedish National Patient Register.瑞典国家患者登记处多发性硬化症诊断的验证。
Eur J Epidemiol. 2019 Dec;34(12):1161-1169. doi: 10.1007/s10654-019-00558-7. Epub 2019 Sep 6.
10
German translation, cultural adaptation and validation of the unidimensional self-efficacy scale for multiple sclerosis.将多维多发性硬化症自我效能感量表进行德文翻译、文化调适和验证。
BMC Neurol. 2021 Apr 17;21(1):163. doi: 10.1186/s12883-021-02183-y.

引用本文的文献

1
Large-scale online assessment uncovers a distinct Multiple Sclerosis subtype with selective cognitive impairment.大规模在线评估发现一种具有选择性认知障碍的独特多发性硬化症亚型。
Nat Commun. 2025 Sep 3;16(1):6938. doi: 10.1038/s41467-025-62156-4.
2
The relationship between ethnicity and multiple sclerosis characteristics in the United Kingdom: A UK MS Register study.英国的种族与多发性硬化症特征之间的关系:一项英国多发性硬化症登记研究。
Mult Scler. 2024 Oct;30(11-12):1544-1555. doi: 10.1177/13524585241277018. Epub 2024 Sep 20.
3
Algorithmic approach to finding people with multiple sclerosis using routine healthcare data in Wales.
使用威尔士常规医疗保健数据发现多发性硬化症患者的算法方法。
J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1032-1035. doi: 10.1136/jnnp-2024-333532.
4
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations.三个大型多发性硬化症群体中疾病修饰疗法的起始模式
Ther Adv Neurol Disord. 2024 Mar 15;17:17562864241233044. doi: 10.1177/17562864241233044. eCollection 2024.
5
The impact of healthcare systems on the clinical diagnosis and disease-modifying treatment usage in relapse-onset multiple sclerosis: a real-world perspective in five registries across Europe.医疗保健系统对复发型多发性硬化症临床诊断和疾病改善治疗使用情况的影响:欧洲五个登记处的真实情况
Ther Adv Neurol Disord. 2023 Sep 26;16:17562864231198963. doi: 10.1177/17562864231198963. eCollection 2023.
6
Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case-control study in an English population-based cohort.多发性硬化症的可改变风险因素在不同种族背景下具有一致的作用方向:一项基于英国人群队列的巢式病例对照研究。
J Neurol. 2024 Jan;271(1):241-253. doi: 10.1007/s00415-023-11971-0. Epub 2023 Sep 7.
7
Patient-reported outcomes in multiple sclerosis: a prospective registry cohort study.多发性硬化症患者报告的结局:一项前瞻性注册队列研究。
Brain Commun. 2023 Aug 20;5(4):fcad199. doi: 10.1093/braincomms/fcad199. eCollection 2023.
8
Early depressive symptoms and disability accrual in Multiple Sclerosis: a UK MS Register study.多发性硬化症中早期抑郁症状与残疾累积:一项英国多发性 sclerosis 注册研究。
Sci Rep. 2023 May 24;13(1):8227. doi: 10.1038/s41598-023-34545-6.
9
ADAMS project: a genetic Association study in individuals from Diverse Ancestral backgrounds with Multiple Sclerosis based in the UK.ADAMS 项目:基于英国的多发性硬化症患者的多种族背景下的遗传关联研究。
BMJ Open. 2023 May 17;13(5):e071656. doi: 10.1136/bmjopen-2023-071656.
10
Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices.关于复发缓解型多发性硬化症的疾病修正治疗决策:陈述偏好和真实世界选择。
Patient. 2023 Sep;16(5):457-471. doi: 10.1007/s40271-023-00622-1. Epub 2023 Apr 18.